Hussman Strategic Advisors Inc. bought a new stake in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 105,000 shares of the medical equipment provider’s stock, valued at approximately $1,871,000. Other hedge funds have also [...]
Hussman Strategic Advisors Inc. Takes $1.87 Million Position in NovoCure Limited (NASDAQ:NVCR)
